The Late Effects of Pregnancy on Aortic Dimensions in Patients with Marfan Syndrome.


Journal

Cardiology
ISSN: 1421-9751
Titre abrégé: Cardiology
Pays: Switzerland
ID NLM: 1266406

Informations de publication

Date de publication:
2021
Historique:
received: 04 10 2019
accepted: 23 08 2020
pubmed: 26 11 2020
medline: 1 9 2021
entrez: 25 11 2020
Statut: ppublish

Résumé

While the immediate effects of pregnancy on aortic dimension in patients with Marfan syndrome (MFS) have been evaluated, the late effects of subsequent pregnancies in these patients are less known. For this purpose, we evaluated 2 groups of women with MFS who were under specialized care in our institution. Group A included 23 women with MFS who experienced 55 pregnancies; group B included 12 nulliparous MFS patients. Patients in group A were similar in age (36.13 ± 5.6 years vs. 34.25 ± 6.54 years, p = 0.41) and follow-up time (group A 6.05 ± 3.56 years and group B 4.92 ± 3.37 years, p = 0.37). Baseline aortic root diameters as well as the aortic root diameters at follow-up visits were similar between groups (35.60 ± 4.42 vs. 35.08 ± 3.82 mm, p = 0.73, and 37.57 ± 4.66 vs. 37.33 ± 4.83 mm, p = 0.89, respectively). The aortic root diameter increased by 0.5 (0, 2) mm in group A and 1 (0, 4.5) mm in group B (p = 0.54). The rate of aortic dilation per year of follow-up was similar between the groups (0.34 ± 0.52 mm/year in group A vs. 0.55 ± 0.75 mm/year in group B [p = 0.52]). Chronic medical treatment was similar in both groups. Patients in both groups were treated similarly with β-blockers, angiotensin-converting enzyme inhibitors, and angiotensin II receptor blockers. In summary, subsequent pregnancies in patients with MFS were not associated with an increase in the rate of aortic root dilation in these patients.

Identifiants

pubmed: 33238262
pii: 000511127
doi: 10.1159/000511127
doi:

Substances chimiques

Angiotensin II Type 1 Receptor Blockers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

98-105

Informations de copyright

© 2020 S. Karger AG, Basel.

Auteurs

Olga Perelshtein Brezinov (O)

Department of Cardiology, Assuta Ashdod Medical Center, Ashdod, Israel.
The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.

Amihay Shinfeld (A)

Department of Cardiac Surgery, Chaim Sheba Medical Center, Tel Hashomer, Ramat-Gan, Israel.
The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Michael Arad (M)

The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Leviev Heart Center, Chaim Sheba Medical Center, Tel Hashomer, Ramat-Gan, Israel.

Tal Cahan (T)

The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel Hashomer, Ramat-Gan, Israel.

Michal J Simchen (MJ)

The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel Hashomer, Ramat-Gan, Israel.

Rafael Kuperstein (R)

The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, rafikupe@gmail.com.
Leviev Heart Center, Chaim Sheba Medical Center, Tel Hashomer, Ramat-Gan, Israel, rafikupe@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH